Upcoming events – Pfizer's abrocitinib and Myovant's relugolix

Upcoming events – Pfizer's abrocitinib and Myovant's relugolix

Source: 
EP Vantage
snippet: 

Pfizer's abrocitinib heads against Dupixent in atopic dermatitis, while Myovant hopes to raise its Spirits.